Pharmacogenetics is the study of inherited genetic differences in drug metabolic pathways which can affect individual responses to drugs, both in terms of therapeutic effect as well as adverse effects. The term pharmacogenetics is often used interchangeably with the term pharmacogenomics which also investigates the role of acquired and inherited genetic differences in relation to drug response and drug behaviour through a systematic examination of genes, gene products, and inter- and intra-individual variation in gene expression and function
The past few years have seen an upsurge of excitement in the potential cannabidiol, or CBD, to possibly treat many otherwise intractable medical conditions.
Interacting in part with body's endocannabinoid system, CBD has been studied for its anti-inflammatory, analgesic and neuroprotective effects.
For the general public, its potential was dramatically demonstrated by Dr. Sanjay Gupta in 2013 in CNN's "Weed" documentary, when the seizures of a then 8 year-old Charlotte Figi were quelled by the application of CBD oil.
ChoicePGX has embraced the use of CBD in clinical practice.
While cannabis medicine has generally eschewed precise dosages, our network leverages our PGx methodology to create specialty pharmacy products that intimately tracks developments in the fast-evolving field of medicine.
CBD is the abbreviation for cannabidiol, the cannabinoid second only to THC. Recently, research has shown CBD to haveanalgesic and anti-anxiety properties without the psychoactive effects
A laboratory study of cannabidol (CBD) is estrogen receptor positive and estrogen receptor negative breast cancer cells showed that it caused cancer cell death while having little effect on normal breast cells (National Cancer Institute 2017)
Cannabinoids have been studied for anit-inflammatory effects that may play a role in pain relief (National Cancer Institute 2017)
Cannabidol (CBD) taken by month to treat solid tumors that have recurred (National Cancer Institute 2017)